These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18727423)

  • 41. Molecular diagnostic and pathogenesis of hereditary hemochromatosis.
    Santos PCJL; Krieger JE; Pereira AC
    Int J Mol Sci; 2012; 13(2):1497-1511. PubMed ID: 22408404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel observations in hereditary hemochromatosis: potential implications for clinical strategies.
    Swinkels DW; Fleming RE
    Haematologica; 2011 Apr; 96(4):485-8. PubMed ID: 21454877
    [No Abstract]   [Full Text] [Related]  

  • 43. Molecular insights into the pathogenesis of hereditary haemochromatosis.
    Pietrangelo A
    Gut; 2006 Apr; 55(4):564-8. PubMed ID: 16531535
    [No Abstract]   [Full Text] [Related]  

  • 44. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.
    Muckenthaler M; Roy CN; Custodio AO; Miñana B; deGraaf J; Montross LK; Andrews NC; Hentze MW
    Nat Genet; 2003 May; 34(1):102-7. PubMed ID: 12704390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-HFE haemochromatosis.
    Wallace DF; Subramaniam VN
    World J Gastroenterol; 2007 Sep; 13(35):4690-8. PubMed ID: 17729390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hereditary hemochromatosis--a new look at an old disease.
    Pietrangelo A
    N Engl J Med; 2004 Jun; 350(23):2383-97. PubMed ID: 15175440
    [No Abstract]   [Full Text] [Related]  

  • 47. Pathophysiology of hereditary hemochromatosis.
    Fleming RE; Britton RS; Waheed A; Sly WS; Bacon BR
    Semin Liver Dis; 2005 Nov; 25(4):411-9. PubMed ID: 16315135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.
    Truksa J; Peng H; Lee P; Beutler E
    Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10289-10293. PubMed ID: 16801541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered hepatic BMP signaling pathway in human HFE hemochromatosis.
    Bolondi G; Garuti C; Corradini E; Zoller H; Vogel W; Finkenstedt A; Babitt JL; Lin HY; Pietrangelo A
    Blood Cells Mol Dis; 2010 Dec; 45(4):308-12. PubMed ID: 20863724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The iron driven pathway of hepcidin synthesis.
    Deugnier Y
    Gastroenterol Clin Biol; 2010; 34(6-7):351-4. PubMed ID: 20537480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell biology. "Pumping" iron: the proteins.
    Beutler E
    Science; 2004 Dec; 306(5704):2051-3. PubMed ID: 15604397
    [No Abstract]   [Full Text] [Related]  

  • 52. Iron disorders of genetic origin: a changing world.
    Brissot P; Bardou-Jacquet E; Jouanolle AM; Loréal O
    Trends Mol Med; 2011 Dec; 17(12):707-13. PubMed ID: 21862411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iron sensing as a partnership: HFE and transferrin receptor 2.
    Fleming RE
    Cell Metab; 2009 Mar; 9(3):211-2. PubMed ID: 19254564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Theurl M; Lederer D; Haufe H; Dietze O; Strasser M; Datz C; Weiss G
    Am J Clin Nutr; 2008 May; 87(5):1374-83. PubMed ID: 18469261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.
    Pietrangelo A
    Gastroenterology; 2015 Oct; 149(5):1240-1251.e4. PubMed ID: 26164493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation.
    Poli M; Luscieti S; Gandini V; Maccarinelli F; Finazzi D; Silvestri L; Roetto A; Arosio P
    Haematologica; 2010 Nov; 95(11):1832-40. PubMed ID: 20634490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice.
    Gao J; Chen J; De Domenico I; Koeller DM; Harding CO; Fleming RE; Koeberl DD; Enns CA
    Blood; 2010 Apr; 115(16):3374-81. PubMed ID: 20177050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiologic systemic iron metabolism in mice deficient for duodenal Hfe.
    Vujic Spasic M; Kiss J; Herrmann T; Kessler R; Stolte J; Galy B; Rathkolb B; Wolf E; Stremmel W; Hentze MW; Muckenthaler MU
    Blood; 2007 May; 109(10):4511-7. PubMed ID: 17264297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2.
    Schmidt PJ; Fleming MD
    Am J Hematol; 2012 Jun; 87(6):588-95. PubMed ID: 22460705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.
    Guo S; Casu C; Gardenghi S; Booten S; Aghajan M; Peralta R; Watt A; Freier S; Monia BP; Rivella S
    J Clin Invest; 2013 Apr; 123(4):1531-41. PubMed ID: 23524968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.